These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28718409)

  • 1. Metronomic Chemotherapy: Direct Targeting of Cancer Cells after all?
    André N; Tsai K; Carré M; Pasquier E
    Trends Cancer; 2017 May; 3(5):319-325. PubMed ID: 28718409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metronomic Maintenance for High-Risk Pediatric Malignancies: One Size Will Not Fit All.
    André N; Orbach D; Pasquier E
    Trends Cancer; 2020 Oct; 6(10):819-828. PubMed ID: 32601045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
    Kerbel RS
    Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metronomic chemotherapy for cancer treatment: a decade of clinical studies.
    Romiti A; Cox MC; Sarcina I; Di Rocco R; D'Antonio C; Barucca V; Marchetti P
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):13-33. PubMed ID: 23475105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metronomic chemotherapy in cancer treatment: new wine in an old bottle.
    Wu HL; Zhou HX; Chen LM; Wang SS
    Theranostics; 2024; 14(9):3548-3564. PubMed ID: 38948068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metronomic chemotherapy: an attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance.
    Kareva I; Waxman DJ; Lakka Klement G
    Cancer Lett; 2015 Mar; 358(2):100-106. PubMed ID: 25541061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronomic therapy: chemotherapy revisited.
    Noronha V; Krishna MV; Patil V; Joshi A; Banavali SD; Prabhash K
    Indian J Cancer; 2013; 50(2):142-8. PubMed ID: 23979206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metronomic chemotherapy: A relook at its basis and rationale.
    Rajasekaran T; Ng QS; Tan DS; Lim WT; Ang MK; Toh CK; Chowbay B; Kanesvaran R; Tan EH
    Cancer Lett; 2017 Mar; 388():328-333. PubMed ID: 28003122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential clinical promise of 'multimodality' metronomic chemotherapy revealed by preclinical studies of metastatic disease.
    Kerbel RS; Shaked Y
    Cancer Lett; 2017 Aug; 400():293-304. PubMed ID: 28202353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to metronomic chemotherapy and ways to overcome it.
    Riesco-Martinez M; Parra K; Saluja R; Francia G; Emmenegger U
    Cancer Lett; 2017 Aug; 400():311-318. PubMed ID: 28259819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect.
    Bocci G; Kerbel RS
    Nat Rev Clin Oncol; 2016 Nov; 13(11):659-673. PubMed ID: 27184418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a randomized, prospective clinical trial evaluating metronomic chemotherapy in nonmetastatic patients with high-grade, operable osteosarcomas of the extremities: A report from the Latin American Group of Osteosarcoma Treatment.
    Senerchia AA; Macedo CR; Ferman S; Scopinaro M; Cacciavillano W; Boldrini E; Lins de Moraes VL; Rey G; de Oliveira CT; Castillo L; Almeida MT; Borsato ML; Lima E; Lustosa D; Barreto JH; El-Jaick T; Aguiar S; Brunetto A; Greggiani L; Cogo-Moreira H; Atallah A; Petrilli AS
    Cancer; 2017 May; 123(6):1003-1010. PubMed ID: 28263383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metronomic chemotherapy from rationale to clinical studies: a dream or reality?
    Gnoni A; Silvestris N; Licchetta A; Santini D; Scartozzi M; Ria R; Pisconti S; Petrelli F; Vacca A; Lorusso V
    Crit Rev Oncol Hematol; 2015 Jul; 95(1):46-61. PubMed ID: 25656744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor endothelial cells as a potential target of metronomic chemotherapy.
    Kim JY; Kim YM
    Arch Pharm Res; 2019 Jan; 42(1):1-13. PubMed ID: 30604201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metronomic chemotherapy for advanced breast cancer patients.
    Cazzaniga ME; Dionisio MR; Riva F
    Cancer Lett; 2017 Aug; 400():252-258. PubMed ID: 28017894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metronomic reloaded: Theoretical models bringing chemotherapy into the era of precision medicine.
    Benzekry S; Pasquier E; Barbolosi D; Lacarelle B; Barlési F; André N; Ciccolini J
    Semin Cancer Biol; 2015 Dec; 35():53-61. PubMed ID: 26361213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metronomic chemotherapy and nanocarrier platforms.
    Abu Lila AS; Ishida T
    Cancer Lett; 2017 Aug; 400():232-242. PubMed ID: 27838415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP-binding cassette transporters in tumor endothelial cells and resistance to metronomic chemotherapy.
    Hida K; Kikuchi H; Maishi N; Hida Y
    Cancer Lett; 2017 Aug; 400():305-310. PubMed ID: 28216371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METRO1: A Phase I Study of Metronomic Chemotherapy in Adults with Advanced Refractory Solid Tumors.
    Launay S; Sabatier R; Brunelle S; Esterni B; Tarpin C; Viret F; Gravis G; Cappiello M; Provansal M; Extra JM; Bertucci F; Viens P; Goncalves A
    Anticancer Res; 2016 Jan; 36(1):293-9. PubMed ID: 26722056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy Between Low Dose Metronomic Chemotherapy and the pH-centered Approach Against Cancer.
    Koltai T; Cardone RA; Reshkin SJ
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31683667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.